MedTrace Logo

Identification of Prognostic Factors and Role of Radiotherapy in Patients With Ewing Sarcoma

NCT06243588 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2025-03-05

No results posted yet for this study

Summary

assess whether there is a correlation between some factors (age, sex, tumor volume, tumor site, chemotherapy-induced necrosis, radiation and biomarkers) and overall survival (OS) and relapse-free survival (RFS) in patients with Ewing sarcoma.

Identification of reliable prognostic factors could help to identify high-risk patients, which may require a different treatment and follow up.

Conditions

  • Ewing Sarcoma

Interventions

OTHER

clinical records review

review the medical records, radiological imaging, and histological data of these patients

Sponsors & Collaborators

  • Istituto Ortopedico Rizzoli

    lead OTHER

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-25
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06243588 on ClinicalTrials.gov